Form 4: OnKure Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Samuel Agresta, Chief Medical Officer of OnKure Therapeutics, Inc., reported multiple transactions in common stock on August 7, 2026.
Summary
- Grant/award: acquired 50,000 Employee Stock Option (right to buy) on August 7, 2026; holds 50,000 after (Direct).
- Disposition to the issuer: disposed of 18,588 Employee Stock Option (right to buy) on August 7, 2026 (Direct).
- Grant/award: acquired 18,588 Employee Stock Option (right to buy) on August 7, 2026; holds 18,588 after (Direct).
- Disposition to the issuer: disposed of 131,396 Employee Stock Option (right to buy) on August 7, 2026 (Direct).
- Grant/award: acquired 131,396 Employee Stock Option (right to buy) on August 7, 2026; holds 131,396 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Samuel Agresta — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Grant/award | Employee Stock Option (right to buy) | 50,000 | — | — | 50,000 |
| 2026-08-07 | Disposition to the issuer | Employee Stock Option (right to buy) | 18,588 | — | — | 0 |
| 2026-08-07 | Grant/award | Employee Stock Option (right to buy) | 18,588 | — | — | 18,588 |
| 2026-08-07 | Disposition to the issuer | Employee Stock Option (right to buy) | 131,396 | — | — | 0 |
| 2026-08-07 | Grant/award | Employee Stock Option (right to buy) | 131,396 | — | — | 131,396 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Grant/award (50,000 shares) |
| 2026-08-07 | Disposition to the issuer (18,588 shares) |
| 2026-08-07 | Grant/award (18,588 shares) |
| 2026-08-07 | Disposition to the issuer (131,396 shares) |
| 2026-08-07 | Grant/award (131,396 shares) |
Keywords
insider transaction, Form 4, OKUR, OnKure Therapeutics, Inc., neutral, Samuel Agresta
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.